Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Gains 5%; BSE HEALTHCARE Index Up 0.1%
Tue, 26 Nov 9:39

MARKSANS PHARMA. Gains 5%; BSE HEALTHCARE Index Up 0.1%Image source: DNY59/www.istockphoto.com

MARKSANS PHARMA. share price has zoomed 5% and is presently trading at Rs 330.7.

Meanwhile, the BSE HEALTHCARE index is at 43,449.3 (up 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 3.2%) and MAX HEALTHCARE INSTITUTE (up 2.1%).

POLY MEDICURE (down 5.9%) and FORTIS HEALTHCARE (down 1.6%) are among the top losers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 139.5 to Rs 330.7, registering a gain of Rs 191.2 (up 137.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,918.9 to 43,449.3, registering a gain of 45.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 166.7%), SUVEN PHARMACEUTICALS (up 111.7%) and Glenmark Pharma (up 94.3%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,362.6 (up 0.3%).

The top gainers among the BSE Sensex today are Infosys (up 2.2%) and Tata Steel (up 1.3%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,312.2 (up 0.4%). Bharat Electronics and Infosys are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.2 to 80,362.6, registering a gain of 14,339.3 points (up 21.7%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit grew 16.6% YoY to Rs 978 million for the quarter ended September 2024, compared to a profit of Rs 839 million a year ago. Net sales rose 20.8% to Rs 6,419 million during the period as against Rs 5,312 million in July-September 2023.

For the year ended March 2024, MARKSANS PHARMA. reported 18.7% increase in net profit to Rs 3,149 million compared to net profit of Rs 2,653 million during FY23. Revenue of the company grew 17.6% to Rs 21,774 million during FY24.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 43.1.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 5%; BSE HEALTHCARE Index Up 0.1%". Click here!